background
ebolaviru
outbreak
result
case
report
death
march
domest
transmiss
guinea
strain
associ
outbreak
occur
mainli
six
african
countri
intern
transmiss
report
four
countri
outbreak
manag
limit
inabl
rapidli
diagnos
infect
case
fifteen
countri
africa
predict
risk
ebolaviru
outbreak
futur
consequ
climat
chang
urban
earli
detect
case
reduct
transmiss
rate
critic
prevent
manag
futur
sever
outbreak
design
rapid
assay
detect
ebolaviru
use
recombinas
polymeras
amplif
rapid
isotherm
amplif
technolog
combin
portabl
later
flow
detect
technolog
develop
rapid
assay
oper
min
compar
realtim
pcr
method
design
screen
select
optim
oligonucleotid
use
np
code
region
ebola
zair
viru
guinea
strain
determin
analyt
sensit
ebola
rapid
molecular
test
test
select
primer
probe
tenfold
serial
dilut
clone
np
gene
mayinga
strain
zair
ebolaviru
pcagg
vector
serial
dilut
cultur
ebolaviru
establish
realtim
pcr
perform
use
fast
mode
test
extract
revers
transcrib
rna
cultur
zair
ebolaviru
strain
mayinga
guecked
guecked
makona
kissidoug
kiwit
determin
analyt
specif
assay
relat
virus
marburg
ebola
reston
ebola
sudan
test
dengu
viru
plasmodium
falciparum
west
nile
viru
kunjin
strain
result
assay
detect
limit
copi
per
plasmid
contain
np
gene
ebolaviru
mayinga
cultur
ebolaviru
highli
specif
zair
ebolaviru
speci
includ
guinea
strain
respons
outbreak
assay
detect
relat
virus
like
marburg
reston
sudan
virus
pathogen
like
isol
clinic
sampl
conclus
assay
could
suitabl
implement
district
primari
health
laboratori
heat
block
centrifug
requir
oper
techniqu
could
provid
pathway
rapid
screen
patient
anim
improv
manag
outbreak
ebolaviru
outbreak
domin
intern
news
world
health
organ
report
case
worldwid
death
initi
outbreak
guinea
decemb
intens
widespread
transmiss
neighbour
countri
includ
sierra
leon
liberia
viru
also
export
mali
nigeria
seneg
unit
state
america
europ
transmiss
drastic
reduc
global
intervent
affect
countri
declar
ebola
free
travel
restrict
lift
nonetheless
countri
africa
predict
risk
ebolaviru
outbreak
base
proxim
peopl
anim
harbour
viru
well
environment
factor
includ
climat
chang
urban
freetown
declar
octob
end
ebola
outbreak
sierra
leon
call
action
reemerg
ebolaviru
includ
improv
laboratori
facil
earli
detect
recent
report
ebolaviru
diseas
evd
outbreak
juli
democrat
republ
congo
laboratori
confirm
case
death
stress
import
action
diagnost
space
earli
laboratori
diagnosi
pivot
prevent
reemerg
ebolaviru
current
laboratori
diagnosi
includ
realtim
polymeras
chain
reaction
rtpcr
antigencaptur
enzymelink
immunosorb
assay
elisa
immunoglobulin
igm
immunoglobulin
g
igg
elisa
addit
recent
ebolaviru
assay
develop
use
antibodi
antigen
detect
isotherm
amplif
technolog
assay
deploy
last
ebola
outbreak
combin
antigenantibodybas
nucleic
acid
test
realstar
zair
ebolaviru
rtpcr
kit
altona
diagnost
hamburg
germani
ebola
assay
cepheid
sunnyval
california
usa
biothreatebola
panel
biofir
salt
lake
citi
utah
usa
reebov
antigen
rapid
test
corgenix
broomfield
colorado
usa
sd
q
line
ebola
zair
ag
test
sd
biosensor
suwon
gyeonggido
republ
korea
deploy
assay
depend
laboratori
capabl
rapid
turnaround
easi
use
ebolaviru
test
devic
howev
assay
consid
futur
detect
viru
futur
ebolaviru
outbreak
predict
affect
countri
africa
addit
molecular
assay
result
compat
clinic
laboratori
lack
pcr
expertis
infrastructur
requir
make
assay
less
relev
technician
resourcelimit
set
detect
viral
rna
proven
effect
diagnosi
ebolaviru
infect
earli
late
stage
ill
howev
standard
rtpcr
ebola
assay
readili
avail
area
need
among
isotherm
technolog
develop
recombinas
polymeras
amplif
rpa
appear
amen
resourc
limit
set
technolog
fast
amplifi
nucleic
acid
min
oper
bodi
temperatur
even
lower
sensit
specif
rpa
compar
pcr
amen
pcrderiv
amplif
detect
strategi
includ
realtim
fluoresc
later
flow
strip
lf
rpa
previous
report
detect
sever
rna
virus
includ
middl
east
respiratori
syndrom
coronaviru
rift
valley
fever
viru
ebolaviru
sever
filovirus
virus
detect
use
portabl
fluoresc
equip
realtim
procedur
describ
rapid
sensit
specif
assay
zair
ebolaviru
includ
current
guinea
strain
assay
use
rpa
rather
use
realtim
fluoresc
imag
assay
use
lf
detect
format
make
result
simpl
interpret
similar
approach
also
use
detect
rna
virus
yellow
fever
viru
chlamydia
trachomati
diagnosi
lf
compon
test
milenia
biotec
giessen
germani
design
detect
rpa
amplicon
duallabel
fam
biotin
suppli
rpa
primer
probe
incorpor
amplif
step
amplicon
captur
goldnanoparticl
label
famspecif
antibodi
sampl
applic
area
travers
immobil
antibiotin
antibodi
bound
test
line
precipit
gold
nanoparticl
test
line
result
appear
redblu
band
excess
gold
nanoparticl
also
captur
speciesspecif
antibodi
bound
control
line
appear
redblu
band
control
line
confirm
correct
oper
strip
absenc
duallabel
amplicon
assay
use
rpalf
method
highli
amen
lowresourc
laboratori
potenti
deploy
futur
ebolaviru
outbreak
aim
studi
develop
assay
compar
faster
rtpcr
easi
interpret
result
addit
sought
assay
could
easili
deploy
outbreak
situat
limit
resourc
preclud
pcr
laboratori
facil
ebolaviru
strain
relat
virus
tabl
grown
vero
cell
harvest
infect
cell
cultur
supernat
centrifug
g
stock
determin
pfuml
standard
plaqu
assay
use
rna
extract
use
rneasi
mini
kit
qiagen
australia
accord
manufactur
instruct
procedur
manipul
ebolavirusinfect
cultur
perform
biosafeti
level
laboratori
csiro
australian
anim
health
laboratori
sampl
elut
nucleas
free
water
use
revers
transcript
reaction
revers
transcript
perform
use
superscript
iv
revers
transcriptas
thermo
fisher
scientif
usa
random
hexam
thermo
fisher
scientif
usa
accord
manufactur
instruct
result
cdna
use
templat
rpalf
primer
probe
synthes
integr
dna
technolog
iowa
usa
purifi
standard
desalt
assay
first
optimis
use
synthet
gene
fragment
one
isol
access
number
bp
bp
templat
data
shown
optim
primer
ebz
tct
cgt
cct
cag
aaa
gtc
tgg
atg
acg
ccg
ebz
biotintac
ttg
ata
cac
tgg
gat
gac
tct
ttg
ccg
probe
ebz
famcti
act
gaa
tct
gac
atg
gat
tac
cac
aag
atc
idsptr
aca
gca
ggt
ctg
tcc
amplifi
base
pair
fragment
ebolaviru
makona
guinea
strain
access
number
amplif
occur
nucleotid
ebola
rpa
assay
perform
use
nfo
kit
pellet
format
twistdx
cambridg
unit
kingdom
accord
manufactur
instruct
modif
primer
probe
concentr
final
volum
briefli
rehydr
buffer
mix
forward
revers
primer
target
specif
probe
master
mix
ad
dri
reagent
pellet
follow
templat
pellet
resuspend
aspir
dispens
sever
time
reaction
activ
addit
magnesium
acet
mm
reaction
mix
follow
incub
min
amplif
amplifi
product
dilut
run
buffer
milenia
biotec
giessen
germani
ad
sampl
pad
hybridetect
later
flow
strip
milenia
biotec
giessen
germani
strip
place
tube
contain
run
buffer
min
photograph
use
digit
camera
greyscal
convert
imag
analys
use
imagej
softwar
nation
institut
health
md
usa
determin
bandintens
measur
mean
grey
valu
limit
threshold
use
fix
area
measur
subtract
maximum
grey
valu
test
band
averag
two
neighbour
white
space
subtract
band
intens
normal
result
sampl
defin
posit
normalis
band
intens
time
higher
standard
deviat
two
neighbour
white
space
valu
follow
similar
viral
rna
assay
develop
studi
employ
rpa
technolog
establish
limit
detect
use
clone
gene
also
perform
standard
tenfold
dilut
invitro
synthesi
genscript
usa
zair
ebolaviru
np
gene
kikwit
isol
clone
ecorixhoi
site
pcagg
pcagg
test
two
replic
use
realtim
taqman
pcr
previous
describ
ebolaviru
speci
specif
primer
probe
assay
perform
use
superscript
iii
platinum
taq
onestep
quantit
pcr
kit
thermo
fisher
scientif
usa
fast
mode
plasmid
dilut
subsequ
test
rpalf
determin
analyt
sensit
relat
ebolavirus
tabl
dengu
plasmodium
falciparum
west
nile
viru
also
test
rpalf
determin
analyt
specif
assay
establish
rpalf
assay
zair
ebolaviru
speci
specif
rpa
primer
probe
design
base
publish
sequenc
guinea
strain
access
number
use
primerblast
gener
nucleotid
extend
manual
longer
nucleotid
amen
rpa
reaction
label
primer
probe
test
rpa
follow
lf
detect
zair
rpalf
use
synthet
ebolaviru
templat
test
optim
reaction
time
min
optim
reaction
time
min
plu
min
incub
lf
run
buffer
visibl
red
colour
band
control
test
line
observ
posit
control
templat
control
neg
control
one
band
control
region
strip
control
band
strip
indic
valid
rpalf
assay
analyt
sensit
specif
rpalf
assay
detect
threshold
zair
rpalf
determin
use
dilut
seri
plasmid
contain
np
gene
copi
viral
rna
cultur
ebolaviru
compar
result
quantif
use
gold
standard
realtim
pcr
assay
detect
use
zair
rpalf
show
sensit
rtpcr
detect
limit
copi
fig
true
posit
demonstr
imagej
analysi
black
pixel
densiti
imag
analysi
could
perform
field
situat
use
later
flow
reader
note
faint
test
band
templat
neg
control
fig
shown
disappear
use
higher
dilut
rpa
product
later
flow
devic
eg
compar
dilut
use
howev
may
affect
sensit
assay
also
observ
case
high
concentr
hybrid
product
intens
control
band
affect
affect
interpret
result
order
determin
cross
reactiv
analyt
specif
assay
test
cultur
viral
rna
reston
sudan
marburg
virus
well
differ
strain
zair
ebolaviru
speci
tabl
marburg
virus
show
haemorrhag
symptom
ebolavirus
ebola
case
mistaken
marburg
viru
first
discov
also
test
plasmodium
falciparum
dengu
viru
west
nile
viru
kunjin
nsw
strain
pathogen
like
isol
clinic
sampl
geograph
region
zair
ebolaviru
rpalf
show
posit
test
result
expos
marburg
rna
ebolaviru
speci
pathogen
fig
indic
assay
specif
zair
ebolaviru
speci
confirm
specif
demonstr
test
line
consist
appear
expos
viral
rna
cultur
differ
zair
ebolaviru
strain
fig
reliabl
rapid
diagnosi
patient
suspect
evd
critic
prevent
limit
spread
manag
treatment
need
clearli
made
appar
freetown
declar
collect
respons
ebolaviru
outbreak
kill
peopl
made
deleg
african
societi
laboratori
medicin
world
health
organis
freetown
sierra
leon
octob
declar
includ
strong
call
build
strengthen
laboratori
network
prevent
detect
b
c
fig
respond
new
futur
diseas
threat
importantli
innov
diagnost
tool
compar
current
gold
standard
resourcelimit
set
identifi
critic
evd
diagnosi
particular
major
challeng
rtpcr
inappropri
set
lack
expertis
infrastructur
support
implement
typic
pcr
facil
mani
mile
away
district
hospit
critic
need
henc
suspect
evd
sampl
sent
central
facil
take
two
day
patient
awar
statu
delay
major
impact
patient
isol
care
treatment
activ
space
ebola
diagnost
post
outbreak
challeng
still
remain
develop
rapid
sensit
select
ebolaviru
test
undergo
full
regulatori
assess
field
test
test
igmigg
detect
earlystag
diseas
patient
mount
immun
respons
antibodybas
diagnost
detect
ebolaviru
antigen
like
reebov
antigen
rapid
test
corgenix
broomfield
colorado
usa
sd
q
line
ebola
zair
ag
test
sd
biosensor
suwon
gyeonggido
republ
korea
ebola
senova
immunoassay
system
weimar
germani
oraquick
ebola
rapid
antigen
test
orasur
technolog
bethlehem
pennsylvania
usa
reason
easi
oper
offer
rapid
onsit
detect
incorpor
small
quantiti
blood
serum
materi
howev
antibodi
base
diagnost
method
sensit
rtpcr
test
counterpart
thu
current
use
refer
assay
sole
detect
viral
rna
realstar
filoviru
screen
rtpcr
kit
improv
realstar
zair
ebolaviru
rtpcr
kit
version
altona
diagnost
rtpcr
origin
design
research
henc
mostli
includ
labourintens
rna
extract
step
temperaturesensit
reagent
expens
laboratori
equip
need
manual
readout
therefor
highli
train
staff
make
multipl
precis
step
sophist
high
contain
laboratori
deliv
evd
result
turnaround
time
four
h
contrast
autom
system
integr
sampl
purif
nucleic
acid
amplif
detect
target
sequenc
use
rtpcr
addit
lower
risk
technic
personnel
verifi
exampl
autom
system
system
combin
ebola
assay
cepheid
sunnyval
california
usa
abl
deliv
result
h
compani
also
design
autom
semiautom
ebola
assay
ebov
test
biocarti
mechelen
belgium
biothreat
ebola
panel
biofir
salt
lake
citi
utah
usa
pointofcar
system
tend
easili
portabl
kg
come
high
price
tag
contrast
report
molecular
assay
zair
ebolaviru
speci
detect
use
lf
requir
simpl
inexpens
equip
heat
block
later
flow
reader
assay
simpl
fast
compar
current
gold
standard
reduc
infrastructur
requir
technic
need
commonli
associ
rtpcrbase
assay
assay
detect
limit
pcr
fig
highli
specif
zair
ebolaviru
strain
respons
differ
outbreak
sinc
well
recent
outbreak
fig
assay
employ
novel
isotherm
amplif
technolog
rpa
previous
appli
detect
dna
rna
organ
assay
sensit
specif
similar
previous
publish
studi
use
rpa
detect
rna
virus
rpa
yet
demonstr
potenti
detect
nucleic
acid
directli
clinic
sampl
apart
urin
blood
test
anticip
rna
extract
would
need
perform
first
possibl
use
rapid
method
requir
centrifug
speedxtract
nucleic
acid
kit
min
extract
protocol
requir
blood
serum
qiagen
hilden
germani
nucleic
acid
kit
deploy
combin
prototyp
diagnost
employ
real
time
version
rpa
recent
ebolaviru
outbreak
base
magnet
particl
technolog
remov
inhibitor
similarli
although
use
twostep
revers
transcript
approach
sampl
prepar
field
detect
onestep
method
could
use
demonstr
previous
rpadetect
rift
valley
fever
viru
mulv
revers
transcriptas
includ
rpa
reaction
pellet
make
cdna
synthesi
step
easier
amen
resourcelimit
set
addit
dispos
detect
devic
allow
assay
perform
close
system
could
use
prevent
crosscontamin
sampl
contain
spread
amplifi
product
protect
oper
procedur
note
previou
rpa
assay
public
indic
constant
shake
speed
requir
stabl
signal
strip
agit
also
improv
sensit
amplif
time
particularli
detect
limit
low
howev
rpa
perform
without
agit
yet
achiev
similar
sensit
rtpcr
chose
ignor
shake
event
typic
routin
diagnost
laboratori
step
might
forgotten
omit
result
schedul
turnaround
time
routin
diagnost
assay
work
load
possibl
shake
sensit
may
even
improv
could
reduc
reaction
time
min
rpalf
zair
ebolaviru
speci
qualit
assay
combin
technolog
rapid
lowresourc
detect
describ
could
provid
rapid
respons
ebolaviru
outbreak
futur
cost
compon
approxim
usd
per
test
without
sampl
prepar
step
ebolaviru
outbreak
case
diagnos
anoth
epidem
build
similar
scale
critic
take
space
limit
highcontain
facil
consider
therefor
complet
inactiv
ebolaviru
sampl
essenti
allow
specimen
manipul
outsid
biolog
contain
facil
current
test
system
requir
rna
extract
commerci
avail
kit
howev
step
may
easili
replac
use
ls
reagent
invitrogen
corp
carlsbad
ca
success
inactiv
member
filoviru
speci
would
enabl
assay
perform
outsid
high
contain
facil
acceler
turnaround
time
diagnos
evd
case
howev
replac
labourintens
lowthroughput
rna
isol
either
safe
lowcost
highthroughput
version
elimin
rna
extract
complet
still
highli
desir
optimis
ebolaviru
test
version
could
high
potenti
compat
unprocess
clinic
materi
whole
blood
obtain
fingerstick
inde
clanci
colleagu
success
shown
detect
streptococcu
pneumonia
whole
blood
materi
use
isotherm
amplif
approach
rpa
field
trial
ebolaviru
test
optim
version
ebolaviru
outbreak
essenti
yet
imposs
predict
strain
futur
outbreak
may
caus
primer
probe
may
also
detect
futur
strain
genet
divers
within
ebolaviru
particularli
zair
ebolaviru
speci
low
date
maximum
nucleotid
differ
sequenc
minim
divers
also
evid
guinea
strain
show
ident
previou
strain
addit
design
oligonucleotid
util
guinea
strain
detect
previou
strain
demonstr
versatil
may
help
detect
futur
strain
similar
assay
could
design
detect
filoviru
speci
respons
outbreak
develop
ebolaviru
assay
could
implement
lowresourc
laboratori
capac
rtpcr
assay
could
potenti
help
next
outbreak
howev
field
evalu
assay
typic
clinic
set
help
determin
clinic
sensit
specif
respect
area
improv
